MANNATECH INC Defined Benefit Plan, Amortization of Transition Asset (Obligation)
MANNATECH INC (MTEX) reported Defined Benefit Plan, Amortization of Transition Asset (Obligation) of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedBenefitPlanAmortizationOfTransitionAssetObligation · last filed 2026-04-15
- MANNATECH INC defined benefit plan, amortization of transition asset (obligation) for fiscal 2025 was $0.00.
- MANNATECH INC defined benefit plan, amortization of transition asset (obligation) for fiscal 2024 was $0.00.
- MANNATECH INC defined benefit plan, amortization of transition asset (obligation) for fiscal 2023 was $0.00.
- MANNATECH INC defined benefit plan, amortization of transition asset (obligation) for fiscal 2022 was -$3.00K.
| Period end | Defined Benefit Plan, Amortization of Transition Asset (Obligation) 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-04-15 |
| 2024-12-31 | $0.00 10-K · filed 2026-04-15 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-26 |
| 2022-12-31 | -$3.00K 10-K · filed 2024-03-28 |
| 2021-12-31 | -$4.00K 10-K · filed 2023-03-17 |
| 2020-12-31 | -$4.00K 10-K · filed 2022-03-15 |
| 2019-12-31 | -$4.00K 10-K · filed 2021-03-19 |
| 2018-12-31 | -$4.00K 10-K · filed 2020-03-26 |
| 2017-12-31 | -$4.00K 10-K · filed 2019-03-11 |
| 2016-12-31 | -$4.00K 10-K · filed 2018-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |